摘要
糖尿病是目前发展最快的非传染性疾病之一。糖尿病是由胰腺β细胞的破坏或胰岛素抵抗引起的,并以高血糖为特征。随着糖尿病药物市场增长非常迅速,糖尿病带来了非常严重的经济危机。即使在非常开创性的科学发现、更好的医疗保健基础设施的提供以及识字率的上升之后,糖尿病负担仍不断在世界各地蔓延,尤其是在中低收入国家。最近的科学发现的发展已经提供了几种新一代的抗糖尿病药物,如磺酰脲、双胍类、噻唑烷二酮、α-葡萄糖苷酶抑制剂。所有这些药物都被证明显著降低了血糖水平。有一些新的低血糖药物也被开发和报道,如GLP-1类似,DPP-IV抑制剂,氨基蛋白抑制剂和过氧化物酶体增殖激活受体。有一些活性分子和生物活性物质已经从草药和植物中纯化,这为对抗糖尿病的战争增加了价值。这些植物成分推翻了药物开发和先导抗糖尿病药物的鉴定。该综述还关注了糖尿病的一些关键领域,更多地关注基于他汀类药物的糖尿病管理方法和基于下一代抗糖尿病治疗的干细胞治疗。
关键词: 抗糖尿病治疗,磺酰脲类药物、GLP-1、DPP-IV、植物成分、淀粉样蛋白、他汀类药物。
Current Medicinal Chemistry
Title:Current Trends in the Therapeutic Strategies for Diabetes Management
Volume: 28 Issue: 23
关键词: 抗糖尿病治疗,磺酰脲类药物、GLP-1、DPP-IV、植物成分、淀粉样蛋白、他汀类药物。
摘要: Diabetes mellitus is one of the fastest-growing non-communicable diseases. Diabetes mellitus is caused due by the destruction of pancreatic β-cell or due to insulin resistance and characterized by hyperglycemia. Diabetes imposes a very serious economic crisis as the diabetic drug market is growing very rapidly. Even after very path-breaking scientific discoveries, the availability of better healthcare infrastructure, and a rise in literacy rates, the diabetes burden is continuously spreading in various sections all over the world but more especially in low- and middle-income countries. The recent developments in scientific discoveries have given several new generations of antidiabetic medicines such as sulphonylurea, biguanides, thiazolidinedione, α-glucosidase inhibitors. All these drugs have proved a significant reduction in blood glucose level. There are some new classes of hypoglycaemic drugs that have also been developed and reported, such as GLP-1 analogous, DPP-IV inhibitors, amylin inhibitors, and peroxisome proliferator- activated receptors. There are some active molecules and bioactive substances that have been purified from herbs and plants, which add value to the war against diabetes. These phytoconstituents have overturned drug development and lead identification for drugs against diabetes. The review also focuses on some critical areas of diabetes with more focus on statin-based diabetes management approach and stem cell therapy based next generation antidiabetic therapy.
Export Options
About this article
Cite this article as:
Current Trends in the Therapeutic Strategies for Diabetes Management, Current Medicinal Chemistry 2021; 28 (23) . https://dx.doi.org/10.2174/0929867328666210218183914
DOI https://dx.doi.org/10.2174/0929867328666210218183914 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements